Shareholders’ equity (deficiency) (Tables)

12 Months Ended

Dec. 31, 2022

Equity [Abstract]

Schedule of Stock Option Activity

A summary of the Company’s option activity and related information is as follows:

	Number of options	Weighted- average exercise price		Weighted- average remaining contractual term (in years)
Outstanding at December 31, 2021	25,487,897	$	2.837	7.03
Granted	1,305,133	6.266
Exercised	4,512,564	2.813
Forfeited	1,822,806	3.629
Outstanding at December 31, 2022	20,457,660	$	2.990	6.39
Exercisable at December 31, 2022	15,913,802	$	2.731	6.00

Schedule of Nonvested Restricted Stock Units Activity

A summary of the Company’s RSUs activity is as follows:

	December 31, 2022
	Number of RSUs
Unvested at beginning of year	2,043,524
Granted	5,912,361
Vested	530,744
Forfeited	1,033,789
Unvested, at end of year	6,391,352

Summary of Stock-Based Compensation

Share based compensation costs are recorded in the consolidated statements of operations were as follows:

	Year Ended December 31,
	2022		2021		2020
Cost of revenues	$	1,283	$	290	$	304
Research and development	2,974		1,076		1,145
Sales and marketing	5,041		2,332		2,298
General and administrative	4,410		2,782		3,524
	$	13,708	$	6,480	$	7,271